These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Wearable cardioverter defibrillator: a life vest till the life boat (ICD) arrives. Francis J; Reek S Indian Heart J; 2014; 66(1):68-72. PubMed ID: 24581099 [TBL] [Abstract][Full Text] [Related]
26. Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death in the real world: Main findings from the French multicentre DAI-PP programme (pilot phase). Boveda S; Garcia R; Defaye P; Piot O; Narayanan K; Barra S; Gras D; Providencia R; Algalarrondo V; Beganton F; Perier MC; Jacob S; Bordachar P; Babuty D; Klug D; Leclercq C; Fauchier L; Sadoul N; Deharo JC; Marijon E; Arch Cardiovasc Dis; 2019; 112(8-9):523-531. PubMed ID: 31471226 [TBL] [Abstract][Full Text] [Related]
27. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator. Klein HU; Goldenberg I; Moss AJ Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691 [TBL] [Abstract][Full Text] [Related]
28. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry. Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M; Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524 [TBL] [Abstract][Full Text] [Related]
30. [The unmet needs of sudden cardiac death. The role of the wearable cardioverter defibrillator when the risk is transient or uncertain]. Guerra F; Palmisano P; Bisignani G; Forleo G; Landolina M; Soldati E; Stabile G; Zanotto G; Berisso MZ; Boriani G; De Ponti R; Ricci RP G Ital Cardiol (Rome); 2020 Oct; 21(10):764-767. PubMed ID: 32968313 [TBL] [Abstract][Full Text] [Related]
31. Time dependence of risks and benefits in pediatric primary prevention implantable cardioverter-defibrillator therapy. DeWitt ES; Triedman JK; Cecchin F; Mah DY; Abrams DJ; Walsh EP; Gauvreau K; Alexander ME Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1057-63. PubMed ID: 25262116 [TBL] [Abstract][Full Text] [Related]
32. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators. Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811 [TBL] [Abstract][Full Text] [Related]
33. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit. Parkash R; Sapp JL; Basta M; Doucette S; Thompson K; Gardner M; Gray C; Brownell B; Kidwai H; Cox J Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):706-13. PubMed ID: 22685111 [TBL] [Abstract][Full Text] [Related]
34. Sudden cardiac death while waiting: do we need the wearable cardioverter-defibrillator? Israel C; Staudacher I; Leclercq C; Botto GL; Scherr D; Fach A; Duru F; Zylla MM; Katus HA; Thomas D Clin Res Cardiol; 2022 Nov; 111(11):1189-1197. PubMed ID: 35305126 [TBL] [Abstract][Full Text] [Related]
35. [Primary prevention of sudden cardiac death through a wearable cardioverter-defibrillator]. Gabrielli D; Benvenuto M; Baroni M; Oliva F; Capucci A G Ital Cardiol (Rome); 2015; 16(7-8):418-25. PubMed ID: 26228611 [TBL] [Abstract][Full Text] [Related]
36. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry). Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618 [TBL] [Abstract][Full Text] [Related]
37. [The subcutaneous implantable cardioverter-defibrillator in clinical practice]. Migliore F; Mattesi G; Zorzi A; Viani S; Bongiorni MG; Francia P; Curcio A; Diemberger I; Bertaglia E G Ital Cardiol (Rome); 2019 Nov; 20(11):641-650. PubMed ID: 31697271 [TBL] [Abstract][Full Text] [Related]
38. The wearable cardioverter-defibrillator: current technology and evolving indications. Reek S; Burri H; Roberts PR; Perings C; Epstein AE; Klein HU; ; Lip G; Gorenek B; Sticherling C; Fauchier L; Goette A; Jung W; Vos MA; Brignole M; Elsner C; Dan GA; Marin F; Boriani G; Lane D; Blomström-Lundqvist C; Savelieva I Europace; 2017 Mar; 19(3):335-345. PubMed ID: 27702851 [TBL] [Abstract][Full Text] [Related]
39. Usefulness of the wearable cardioverter-defibrillator in patients at high risk for sudden cardiac death. Sasaki S; Tomita H; Shibutani S; Izumiyama K; Higuma T; Itoh T; Sasaki K; Horiuchi D; Kimura M; Okumura K Circ J; 2014; 78(12):2987-9. PubMed ID: 25366562 [TBL] [Abstract][Full Text] [Related]
40. Device Therapy for Sudden Cardiac Death Prophylaxis After Acute Coronary Syndrome: When and Why? Beg F; Valderrabano M; Schurmann P Curr Cardiol Rep; 2020 Jan; 22(1):4. PubMed ID: 31950276 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]